Abstract

Abstract Severe Acute Respiratory Syndrome coronavirus 2 (SARS‐CoV‐2) is rapidly spreading around the world. There is no existing vaccine or proven drug to prevent infections and stop virus proliferation. Although this virus is similar to human and animal SARS‐CoVs and Middle East Respiratory Syndrome coronavirus (MERS‐CoVs), the detailed information about SARS‐CoV‐2 proteins structures and functions is urgently needed to rapidly develop effective vaccines, antibodies, and antivirals. We applied high‐throughput protein production and structure determination pipeline at the Center for Structural Genomics of Infectious Diseases to produce SARS‐CoV‐2 proteins and structures. Here we report two high‐resolution crystal structures of endoribonuclease Nsp15/NendoU. We compare these structures with previously reported homologs from SARS and MERS coronaviruses.

Keywords

EndoribonucleaseVirologyCoronavirusMiddle East respiratory syndrome coronavirusSevere acute respiratory syndrome coronavirusVirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Middle East respiratory syndromeBiologyComputational biologyCoronavirus disease 2019 (COVID-19)MedicineGeneGeneticsInfectious disease (medical specialty)RNA

Affiliated Institutions

Related Publications

2019 NOVEL CORONAVIRUS.

In December 2019, the outbreak of a new disease began in Wuhan, Hubei Province, China. The causative agent of the new disease outbreak was identified as 2019 novel Coronavirus 2...

2019 PubMed 19 citations

Publication Info

Year
2020
Type
article
Volume
29
Issue
7
Pages
1596-1605
Citations
360
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

360
OpenAlex

Cite This

Youngchang Kim, R. Jedrzejczak, N. Maltseva et al. (2020). Crystal structure of Nsp15 endoribonuclease <scp>NendoU</scp> from <scp>SARS‐CoV</scp> ‐2. Protein Science , 29 (7) , 1596-1605. https://doi.org/10.1002/pro.3873

Identifiers

DOI
10.1002/pro.3873